Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Anal Bioanal Chem. 2015 Dec 9;408(2):461–471. doi: 10.1007/s00216-015-9154-8

Figure 2. Summary of N-glycan assignments.

Figure 2

Predicted compositions in terms of hexose, N-acetylhexosamine, fucose and phosphorylcholine residues and CFG-type structures are presented together with (i) calculated m/z as [M+H]+ for the pyridylaminated N-glycans, (ii) retention time in terms of glucose units and fraction number (RP-amide column), (iii) a qualitative indication of abundance (trace through to +++), (iv) important MS/MS fragments and (v) notes regarding identical properties as glycans from Pristionchus, sensitivity to chemical and enzymatic treatments and relevant figure (Fig) and supplementary figure (SFig) numbers. For reasons of space, two variants of Man2GlcNAc2 (m/z 827) as well as a Glc1Man9GlcNAc2 (m/z 2123) are not included. The MS/MS of the untreated glycans are also available as supplementary mzXML files.